Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Future of Measles Vaccine in the U.S.A.: Part I

Future of Measles Vaccine in the U.S.A.: Part I Abstract I should first like to pay particular tribute to Dr. Kempe and to the University of Colorado School of Medicine for having brought together into this International Conference such a tremendous amount of information concerning measles, and also for giving us the opportunity of paying such a magnificent and well-deserved tribute to Dr. Enders. I think it would be worthwhile to come round the circle, as it were, to certain items Dr. Wilson reviewed at the very beginning of this conference, namely, those areas that we need to consider in measuring our success or failure, areas which bear directly on the practical aspects of measles immunization in the United States and throughout the world. These were harmlessness, lack of reaction, acceptance by parents and physicians alike, the ease of giving the vaccine, its efficacy, and the herd immunity. In addition to these points Dr. Wilson mentioned, it is well worthwhile http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American Journal of Diseases of Children American Medical Association

Future of Measles Vaccine in the U.S.A.: Part I

American Journal of Diseases of Children , Volume 103 (3) – Mar 1, 1962

Loading next page...
 
/lp/american-medical-association/future-of-measles-vaccine-in-the-u-s-a-part-i-wltgvTWjqE

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Medical Association
Copyright
Copyright © 1962 American Medical Association. All Rights Reserved.
ISSN
0002-922X
DOI
10.1001/archpedi.1962.02080020537081
Publisher site
See Article on Publisher Site

Abstract

Abstract I should first like to pay particular tribute to Dr. Kempe and to the University of Colorado School of Medicine for having brought together into this International Conference such a tremendous amount of information concerning measles, and also for giving us the opportunity of paying such a magnificent and well-deserved tribute to Dr. Enders. I think it would be worthwhile to come round the circle, as it were, to certain items Dr. Wilson reviewed at the very beginning of this conference, namely, those areas that we need to consider in measuring our success or failure, areas which bear directly on the practical aspects of measles immunization in the United States and throughout the world. These were harmlessness, lack of reaction, acceptance by parents and physicians alike, the ease of giving the vaccine, its efficacy, and the herd immunity. In addition to these points Dr. Wilson mentioned, it is well worthwhile

Journal

American Journal of Diseases of ChildrenAmerican Medical Association

Published: Mar 1, 1962

There are no references for this article.